Synonyms:letrozole, 112809-51-5, Femara, 4,4'-((1h-1,2,4-triazol-1-yl)methylene)dibenzonitrile, Letrozol, CGS 20267, CGS-20267, 4-[(4-cyanophenyl)-(1,2,4-triazol-1-yl)methyl]benzonitrile, LETRAZOLE, Benzonitrile, 4,4'-(1H-1,2,4-triazol-1-ylmethylene)bis-, Femera, 4,4'-(1H-1,2,4-Triazol-1-ylmethylene)dibenzonitrile, 4,4'-(1H-1,2,4-triazol-1-ylmethanediyl)dibenzonitrile, 4,4'-(1h-1,2,4-triazol-1-ylmethylene)bisbenzonitrile, NSC-759652, CHEMBL1444, 4-[(4-CYANOPHENYL)(1H-1,2,4-TRIAZOL-1-YL)METHYL]BENZONITRILE, 4,4'-(1h-1,2,4-triazol-1-ylmethylene)bis-benzonitrile, 7LKK855W8I, CHEBI:6413, DTXSID4023202, 4,4'-(1h-1,2,4-triazol-1-ylmethylene) bis-benzonitrile, NCGC00016973-01, Letoval, CAS-112809-51-5, DTXCID503202, SMR000466343, Femara (TN), HSDB 7461, SR-01000759382, Letrozole (JAN/USP/INN), UNII-7LKK855W8I, CCRIS 8822, 1-[bis(4-cyanophenyl)methyl]-1,2,4-triazole, FEM-345, Femara, Letrozole, Letrozole [USAN:USP:INN:BAN], Letrozole- Bio-X, CGS20267, MFCD00866241, LETROZOLE [INN], LETROZOLE [JAN], LETROZOLE [MI], LETROZOLE [HSDB], LETROZOLE [USAN], Prestwick0_001025, Prestwick1_001025, Prestwick2_001025, Prestwick3_001025, Femara (TN) (Novartis), LETROZOLE [MART.], LETROZOLE [USP-RS], LETROZOLE [WHO-DD], SCHEMBL4331, 1-[Bis-(4-cyanophenyl)methyl]-1,2,4-triazole, BIDD:PXR0130, BSPBio_001209, MLS000759455, MLS001424038, MLS002584991, MLS006010040, BIDD:GT0015, SPBio_003070, BPBio1_001331, GTPL5209, LETROZOLE [EP IMPURITY], LETROZOLE [ORANGE BOOK], LETROZOLE [EP MONOGRAPH], Letrozole, >=98% (HPLC), BDBM13061, EX-A965, LETROZOLE [USP MONOGRAPH], HMS1571M11, HMS2051E08, HMS2089L22, HMS2098M11, HMS2233C23, HMS3369E11, HMS3393E08, HMS3651K05, HMS3715M11, Pharmakon1600-01502354, AMY32541, BCP23354, Tox21_110719, Tox21_303572, NSC719345, NSC759652, s1235, STL451047, AKOS005145822, AB07525, AC-1193, BCP9000848, CCG-100849, CS-1776, DB01006, KS-1269, NC00099, NSC 759652, NSC-719345, NCGC00016973-02, NCGC00016973-03, NCGC00016973-06, NCGC00257460-01, BL164620, HY-14248, BCP0726000213, 1-Bis(4-cyanophenyl)methyl-1,2,4-triazole, 4,2,4-Triazol-1-ylmethylene)dibenzonitrile, AB00514009, L0248, SW197294-4, A25380, C08163, D00964, EN300-264820, AB00514009-05, AB00514009-07, AB00514009-08, AB00514009-09, AB00514009_10, AB00514009_11, KISQALI FEMARA CO-PACK COMPONENT LETROZOLE, Q194974, W-60273, 4,4'-(1,2,4-Triazol-1-ylmethylene)dibenzonitrile, LETROZOLE COMPONENT OF KISQALI FEMARA CO-PACK, Q-201291, SR-01000759382-4, SR-01000759382-5, BRD-K88789588-001-03-2, 4,4 -(1H-1,2,4-triazol-1-ylmethanediyl)dibenzonitrile, 4,4'-(1h-1,2,4-triazol-1-ylmethylene)-bisbenzonitrile, F2173-0288, Z1741968261, 4,4'-((1H-1,2,4-Triazol-1-yl)-methylene)dibenzonitrile, Letrozole, European Pharmacopoeia (EP) Reference Standard, Letrozole, United States Pharmacopeia (USP) Reference Standard, 4-[1-(4-CYANOPHENYL)-1-(1,2,4-TRIAZOL-1-YL)METHYL]BENZONITRILE, Letrozole, Pharmaceutical Secondary Standard; Certified Reference Material
Pubchem:PUBCHEM:3902
Id:64f72b03-e0f0-5919-9b8c-bcb05d2f2d4f
Description:nan
